Alfredo Addeo, Department of Oncology at the University Hospital of Geneva, shared on X:
“Great point by Charu Aggarwal! Not all comprehensive genomic tests are created equal.
Different assays, different coverage, different results, with real implications for biomarker detection, patient selection and ultimately treatment decisions. The test you choose matters!”
